Atlas Trials

Trial of Oxaloacetate in Alzheimer's Disease (TOAD)

Clinical trial NCT02593318 · COMPLETED

Trial details

NCT number
NCT02593318
Sponsor
Russell Swerdlow
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease (AD)
Start date
2015-10-01
Primary completion
2018-09-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.